Postoperative urinary retention (POUR) is one of the most common complications following surgery and anesthesia, affecting 5–70% of patients depending on the procedure and population. Green tea — consumed globally as a health beverage — has increasingly recognized effects on the lower urinary tract. Yet its specific relationship with POUR remains uncharted in the clinical literature. This article synthesizes current mechanistic and clinical evidence to guide informed perioperative counseling.
What Is Postoperative Urinary Retention?
POUR is defined as the inability to voluntarily void after surgery, typically operationalized as a bladder volume exceeding 400–600 mL without spontaneous micturition. Its pathophysiology is multifactorial: general and neuraxial anesthesia impair detrusor contractility and suppress voiding reflexes; opioid analgesics activate μ-receptors in the sacral spinal cord and bladder neck, increasing urethral resistance and inhibiting detrusor contraction; anticholinergic agents blunt bladder contractility; and immobility reduces afferent proprioceptive cues that normally trigger the voiding reflex.
Independent risk factors include benign prostatic hyperplasia (BPH), prior pelvic surgery, diabetes mellitus with autonomic neuropathy, advanced age, and prolonged operative duration. POUR often requires urethral catheterization and, if unrecognized, can lead to bladder overdistension injury, autonomic dysreflexia, and long-term voiding dysfunction.
Pharmacologically Active Constituents of Green Tea
Green tea (Camellia sinensis, unfermented) delivers two pharmacologically relevant fractions to the lower urinary tract:
Polyphenolic catechins — primarily epigallocatechin-3-gallate (EGCG) and epigallocatechin (EGC). These compounds exhibit anti-inflammatory, antioxidant, anti-fibrotic, and direct neuroprotective effects. Crucially, EGC — unlike most catechins — is excreted into urine at potentially therapeutic concentrations, making it bioavailable precisely where it may matter for bladder health.
Caffeine — present at approximately 20–50 mg per 240 mL cup, less than coffee but pharmacologically active. Caffeine acts as an adenosine receptor antagonist and a mild diuretic, increasing urine production and potentially irritating the urothelium at higher doses.
The net effect of green tea on the bladder represents the balance between these two competing influences.
Mechanisms Relevant to POUR
The following framework organizes green tea's bidirectional effects on the postoperative bladder:
- EGCG neuroprotection: Animal models show dose-dependent preservation of bladder nerve integrity and reduction in involuntary contractions
- Anti-fibrosis: EGCG prevents bladder wall stiffening, preserving detrusor compliance
- Anti-inflammatory: Catechins reduce urothelial inflammation and bladder wall edema
- Reduced PVR: A 12-week RCT in men with LUTS/BPH showed significant reduction in post-void residual volume with 1000 mg green/black tea extract
- Reduced LUTS scores: AUA symptom index fell 34.5% with 1000 mg/day supplementation
- Diuretic effect: Caffeine increases urine production — if the patient cannot void, bladder overdistension worsens
- Bladder irritation: High doses can irritate the urothelium, increasing urgency symptoms
- Volume load: High fluid intake accelerates bladder filling before anesthesia-suppressed voiding reflexes recover
- Drug interactions: Caffeine may interact with anesthetic agents; catechins inhibit certain hepatic CYP enzymes
Summary of Relevant Clinical Evidence
| Study / Source | Population | Finding | Evidence Level |
|---|---|---|---|
| Hirayama & Lee, Neurourol Urodyn 2011 | 298 women, 40–75 yr | ≥4 cups/day → 66% lower odds of urinary incontinence (OR 0.34) | Moderate |
| Katz et al., Ther Adv Urol 2014 (AMH trial) | 46 men with LUTS/BPH | 1000 mg green+black tea extract → 34.5% ↓ AUAss, ↓ PVR, ↑ Qmean at 12 wk | Moderate (RCT) |
| Animal models (EGCG, ovariectomized rats) | Rodent surgical menopause | EGCG prevented overactive bladder: neuroprotection, anti-fibrosis, antioxidant mechanisms | Low (animal) |
| Chancellor et al., AUA Annual Meeting 2007 | In vitro urothelial cells | EGCG and ECG protected bladder cells from oxidative injury; anti-inflammatory in interstitial cystitis | Low (in vitro) |
| Green tea vs. POUR (specific) | — | No published RCTs or observational studies addressing this specific endpoint | None |
Applying This to the Perioperative Patient
Pre-operative counseling
Patients who are habitual green tea consumers (≥2–4 cups/day) are unlikely to face increased POUR risk from their baseline habit. The chronic anti-inflammatory and anti-fibrotic effects of EGCG may, if anything, confer modest long-term bladder benefit — particularly in older men with subclinical BPH. There is no evidence supporting preoperative cessation of moderate green tea consumption specifically to prevent POUR.
However, clinicians should note that high-volume green tea intake on the day of surgery (beyond standard clear fluid allowances per ERAS protocols) could increase bladder volume at the time of anesthetic induction, contributing to early postoperative bladder overdistension if the voiding reflex is suppressed.
Intraoperative and anesthetic context
The dominant determinants of POUR remain anesthetic technique (neuraxial > general), opioid dose, anticholinergic burden, and operative duration. Green tea's pharmacological contribution is physiologically minor in comparison. Caffeine's interaction with volatile anesthetic MAC has not been specifically studied and is not clinically established as a meaningful variable.
Postoperative management
In the immediate postoperative period, if POUR is present or suspected, resuming green tea consumption before the patient can void adds a diuretic load at an inopportune moment. Conservative advice would be to hold caffeinated beverages — including green tea — until spontaneous voiding is documented. Once voiding is re-established, resumption is appropriate and, for patients with BPH, may even provide supportive benefit to lower urinary tract symptoms.
- No direct evidence links green tea consumption to postoperative urinary retention.
- EGCG (catechin fraction) has neuroprotective, anti-fibrotic, and anti-inflammatory effects on bladder tissue that may be modestly beneficial in the long term.
- Caffeine (diuretic fraction) can worsen bladder overdistension if POUR is present; withhold caffeinated green tea until spontaneous voiding is confirmed.
- Dominant POUR risk factors (opioids, neuraxial anesthesia, BPH, anticholinergics) dwarf any effect attributable to green tea.
- For patients with LUTS/BPH, habitual green tea consumption (1–4 cups/day) may provide complementary long-term support to pharmacological management.
- Decaffeinated green tea extract supplements may offer EGCG benefits without the diuretic burden — a theoretically favorable option peri-operatively.
Research Gaps and Future Directions
The absence of any prospective study examining green tea consumption and POUR is notable. Such a study would ideally stratify by: habitual intake (cups/day), timing relative to surgery, anesthetic type, BPH status, and EGCG vs. caffeine content. Animal models suggest that EGCG pretreatment before surgical stress (including surgical menopause) protects bladder function — a concept that could translate to perioperative bladder conditioning in at-risk populations.
An RCT examining decaffeinated EGCG supplementation in patients with known BPH undergoing elective surgery would fill a meaningful evidence gap. Given the safety profile of green tea extract, the bar for such a trial is low.
References
- Hirayama F, Lee AH. Green tea drinking is inversely associated with urinary incontinence in middle-aged and older women. Neurourology and Urodynamics. 2011;30(7):1262–1265.
- Katz AE, Herrlinger K, Chirouzes D, Ceddia M. Efficacy of a green and black tea extract on urological health in men with lower urinary tract symptoms. Therapeutic Advances in Urology. 2014;6(3):89–96.
- Chancellor MB et al. Green tea catechins protect bladder cells from inflammation. Presented at: AUA Annual Meeting; 2007; Anaheim, CA.
- Reygaert WC, Jusufi I. Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli. Frontiers in Microbiology. 2013;4:162.
- Kheirabadi Z et al. Green tea as an adjunctive therapy for treatment of acute uncomplicated cystitis in women. Complementary Therapies in Clinical Practice. 2019;34:13–16.
- Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009;110(5):1139–1157.
- Keske MA et al. EGCG effects on bladder neuroprotection and fibrosis in experimental surgical menopause. Neurourology and Urodynamics. 2012.